Caroline Baumal, MD

home / authors / caroline-baumal-md

New England Eye Center, Boston, Massachusetts

Articles

Take-Home Points for the Treatment of AMD and DME

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.

Unmet Needs in AMD and DME

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

Drs David A. Eichenbaum and Caroline Baumal discuss unmet needs in treating AMD and DME.

Incorporating Faricimab in Clinical Practice

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

Retina specialists discuss how to incorporate faricimab into clinical practice and discuss implacations of the TRUCKEE study.

MOA of Faricimab and 2-Year Data Review

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

David A. Eichenbaum, MD, FASRS, and Caroline Baumal, MD, review the dual mechanism of action of faricimab as well as the 2-year update in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials.

Implications of Treat-and-Extend With Faricimab in AMD

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

Drs David A. Eichenbaum and Caroline Baumal discuss implications of the treat-and-extend approach with faricimab in patients with wet AMD.

AMD and DME: Factors Affecting Treatment Selection and the Importance of Shared Decision-Making

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

Retina specialists discuss which factors impact treatment selection and how to incorporate shared decision-making into treatment selection when treating patients with AMD and DME.

Impact of AMD and DME on Quality of Life

David A. Eichenbaum, MD;Caroline Baumal, MD

August 30th 2022

David A. Eichenbaum, MD, FASRS, and Caroline Baumal, MD, discuss how AMD and DME impact a patient’s quality of life.